NO20082358L - S-omeprazol-stronsium eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat omfattende disse - Google Patents

S-omeprazol-stronsium eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat omfattende disse

Info

Publication number
NO20082358L
NO20082358L NO20082358A NO20082358A NO20082358L NO 20082358 L NO20082358 L NO 20082358L NO 20082358 A NO20082358 A NO 20082358A NO 20082358 A NO20082358 A NO 20082358A NO 20082358 L NO20082358 L NO 20082358L
Authority
NO
Norway
Prior art keywords
hydrate
preparation
pharmaceutical composition
omeprazole
stronsium
Prior art date
Application number
NO20082358A
Other languages
English (en)
Inventor
Eun Young Kim
Tae Hee Ha
Hee Sook Oh
Won Jeoung Kim
Chang Hee Park
Young Hoon Kim
Kwee Hyun Suh
Gwan Sun Lee
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of NO20082358L publication Critical patent/NO20082358L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Oppfinnelsen tilveiebringer S-omeprazolstrontium eller et hydrat derav for forhindring eller behandling av en magesyre-relatert sykdom, som har høy optisk renhet, termostabilitet, løselighet og ikke-hygroskopisitet, en fremgangsmåte for fremstilling derav, og et farmasøytisk preparat omfattende dette.
NO20082358A 2005-10-26 2008-05-23 S-omeprazol-stronsium eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat omfattende disse NO20082358L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20050101059 2005-10-26
KR2006000760 2006-03-06
PCT/KR2006/004369 WO2007049914A1 (en) 2005-10-26 2006-10-25 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same

Publications (1)

Publication Number Publication Date
NO20082358L true NO20082358L (no) 2008-07-25

Family

ID=37967988

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082358A NO20082358L (no) 2005-10-26 2008-05-23 S-omeprazol-stronsium eller hydrat derav, fremgangsmate for fremstilling derav, og farmasoytisk preparat omfattende disse

Country Status (8)

Country Link
JP (1) JP5017274B2 (no)
AU (1) AU2006306906B2 (no)
CA (1) CA2626085C (no)
IL (1) IL190709A (no)
MY (1) MY140986A (no)
NO (1) NO20082358L (no)
RU (1) RU2372345C1 (no)
WO (1) WO2007049914A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
CN116102538A (zh) * 2023-01-29 2023-05-12 山东省分析测试中心 一种转晶制备三水合艾司奥美拉唑镁的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
WO2004099182A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Zinc salt of (s)-omeprazole
SI1651217T1 (sl) * 2003-07-23 2008-08-31 Nycomed Gmbh Alkalne soli inhibitorjev protonske ÄŤrpalke
KR20080007508A (ko) * 2005-05-06 2008-01-21 그렌마크 파머수티칼스 엘티디. 에소메프라졸 스트론튬염, 그것의 제조방법 및 그것을함유하는 약제학적 조성물

Also Published As

Publication number Publication date
JP2009513625A (ja) 2009-04-02
AU2006306906B2 (en) 2010-02-04
CA2626085C (en) 2011-12-06
MY140986A (en) 2010-02-12
JP5017274B2 (ja) 2012-09-05
WO2007049914A1 (en) 2007-05-03
CA2626085A1 (en) 2007-05-03
IL190709A0 (en) 2008-11-03
RU2372345C1 (ru) 2009-11-10
IL190709A (en) 2012-03-29
AU2006306906A1 (en) 2007-05-03

Similar Documents

Publication Publication Date Title
NO20092274L (no) Ansamycinformuleringer og fremgangsmater for anvendelse derav
NO20091700L (no) Florizinanaloger som inhibitorer av glukose-ko-transporter 2
HK1104035A1 (en) Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same
NO20053972L (no) Aminosyre-avledede prodrug av propofol, sammensetninger og anvendelse derav.
NO20092609L (no) Tannate salt of rasagiline
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
NO20083923L (no) Pyrazolkinoloner er potente parp-inhibitorer
DK1984357T3 (da) 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
DK1971601T3 (da) N4-phenyl-quinazolin-4-aminderivater og beslægtede forbindelser som ERBB Type 1-receptortyrosinkinase-inhibitorer til behandling af hyperproliferative sygdomme
WO2007003962A3 (en) Gpcr agonists
NO20085004L (no) Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler
NO20080122L (no) Blanding av diisononylestere av 1,2syklodikarbonsyrer, fremgangsmate for dere fremstilling og anvendelse derav
TN2009000111A1 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
NO20092398L (no) Krystallinske former av solvatisert ilaprazol
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
WO2007120575A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
NO20081160L (no) Benzimidazoltiofen forbindelser
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20082758L (no)
WO2007075749A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
NO20082938L (no) Formuleringer av quinolinoner
DK1879580T3 (da) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinolinderivater som lægemidler til behandling af infertilitet
BRPI0622083A2 (pt) Método e aparelho destinados à fabricação de substratos purificados ou substratos puros que são adicionalmente processados.
NO20083751L (no) Metoder for behandling av kognitive og andre sykdommer

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: TANDBERGS PATENTKONTOR AS, POSTBOKS

FC2A Withdrawal, rejection or dismissal of laid open patent application